{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:15Z","timestamp":1792784235612,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R303-A17533-21-S3"],"award-info":[{"award-number":["R303-A17533-21-S3"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R303-A17533-21-S3"],"award-info":[{"award-number":["R303-A17533-21-S3"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Herlev and Gentofte Hospital Research fund","id":[{"id":"https:\/\/ror.org\/051dzw862","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Holm's Memorial Fund","award":["21093"],"award-info":[{"award-number":["21093"]}]},{"name":"Copenhagen University","id":[{"id":"https:\/\/ror.org\/035b05819","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The MELACARE intervention aimed to evaluate a nurse-led follow-up program incorporating skin self-examination (SSE) education and psychosocial support to address fear of cancer recurrence (FCR) in early-stage melanoma survivors. This study assessed the MELACARE intervention\u2019s impact on FCR, psychological well-being, SSE performance, and healthcare usage compared to standard physician-led follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A two-group randomised controlled trial was conducted at Herlev and Gentofte Hospital, Denmark. Participants included 153 patients with surgically treated melanoma (stages IA\u2013IIA). Patients were randomised to either the MELACARE intervention (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200978) or a control group provided treatment as usual (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200975). The intervention involved nurse-led sessions focusing on SSE techniques and metacognitive strategies. Outcomes included FCR (primary), distress, anxiety, depression, health-related quality of life (HRQoL), patient activation, and SSE frequency and confidence (secondary) at 6 months. Trial registration: ClinicalTrials.gov (NCT05253872).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 6 months, the mean of the primary outcome FCR was lower in the intervention compared to the control groups, but the difference was not statistically significant (\u2212\u20090.86 [\u2212\u20093.34;1.62]). Intervention patients reported higher HRQoL (18% [3;32]) and patient activation (0.43 [0.15;0.71]) as the only significant secondary outcomes. Confidence in SSE was higher in the intervention group, with most performing SSE at recommended intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The MELACARE intervention may improve HRQoL and patient activation but did not reduce FCR. High fidelity of delivery and patient adherence highlight its potential utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>The MELACARE approach empowers melanoma survivors through structured SSE education and psychosocial support. Future analyses will investigate long-term safety and efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-025-01841-1","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:58:49Z","timestamp":1749722329000},"page":"606-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Employing skin self-examination and fear of cancer recurrence management in early-stage melanoma follow-up: evaluation of the MELACARE intervention in a randomised controlled trial"],"prefix":"10.1007","volume":"20","author":[{"given":"Sara M\u00f8lgaard","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine A.","family":"Kasparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia Klinten","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille Envold","family":"Bidstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbet Rosenkrantz","family":"H\u00f6lmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"1841_CR1","unstructured":"Melanomgruppen. Melanoma.dk [Internet]. Melanom.dk; [cited 2025 May 9]. Available from: https:\/\/www.melanoma.dk\/."},{"key":"1841_CR2","unstructured":"International Agency for Research on Cancer (IARC). Global cancer observatory [Internet]. Lyon: IARC; [cited 2025 May 9]. Available from: https:\/\/gco.iarc.fr\/en"},{"key":"1841_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022. Eur J Cancer. 2022;170:236\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008.","journal-title":"Eur J Cancer"},{"key":"1841_CR4","unstructured":"National Comprehensive Cancer Network N. NCCN guidelines version 3.2023 Melanoma: cutaneous [Internet]. 2023 [cited 2023 Nov 17]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf. Accessed 9 May 2025"},{"key":"1841_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11764-010-0165-3","volume":"5","author":"NJ Davies","year":"2011","unstructured":"Davies NJ, Batehup L. Towards a personalised approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv. 2011;5:142\u201351. https:\/\/doi.org\/10.1007\/s11764-010-0165-3.","journal-title":"J Cancer Surviv"},{"key":"1841_CR6","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-007-9347-2","volume":"14","author":"AB Francken","year":"2007","unstructured":"Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14:1924\u201333. https:\/\/doi.org\/10.1245\/s10434-007-9347-2.","journal-title":"Ann Surg Oncol"},{"key":"1841_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00238-022-01997-4","volume":"46","author":"JT Johannessen","year":"2023","unstructured":"Johannessen JT, Nguyen TD, Holmboe S, Rindom MB, Stolle LB. Evaluating the effect of detection modalities in the Danish clinical follow-up program of cutaneous melanoma\u2014a retrospective cohort study. Eur J Plast Surg. 2023;46:251\u20139. https:\/\/doi.org\/10.1007\/s00238-022-01997-4.","journal-title":"Eur J Plast Surg"},{"key":"1841_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00238-024-02210-4","volume":"47","author":"N Hosseinpour","year":"2024","unstructured":"Hosseinpour N, Toyserkani NM. Evaluating the yield of adhering to the follow-up guidelines for cutaneous melanoma: a retrospective study of 2048 patients. Eur J Plast Surg. 2024;47:63. https:\/\/doi.org\/10.1007\/s00238-024-02210-4.","journal-title":"Eur J Plast Surg"},{"key":"1841_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012425.pub2","author":"BL H\u00f8eg","year":"2019","unstructured":"H\u00f8eg BL, Bidstrup PE, Karlsen RV, Friberg AS, Albieri V, Dalton SO, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD012425.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1841_CR10","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1245\/s10434-020-08758-2","volume":"27","author":"MD Moncrieff","year":"2020","unstructured":"Moncrieff MD, Underwood B, Garioch JJ, Heaton M, Patel N, Bastiaannet E, et al. The MelFo study UK: effects of a reduced-frequency, stage-adjusted follow-up schedule for cutaneous melanoma 1B to 2C patients after 3-years. Ann Surg Oncol. 2020;27:4109\u201319. https:\/\/doi.org\/10.1245\/s10434-020-08758-2.","journal-title":"Ann Surg Oncol"},{"key":"1841_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archderm.143.1.37","volume":"143","author":"JK Robinson","year":"2007","unstructured":"Robinson JK, Turrisi R, Stapleton J. Efficacy of a partner assistance intervention designed to increase skin self-examination performance. Arch Dermatol. 2007;143:37\u201341. https:\/\/doi.org\/10.1001\/archderm.143.1.37.","journal-title":"Arch Dermatol"},{"key":"1841_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.bjc.6605638","volume":"102","author":"P Murchie","year":"2010","unstructured":"Murchie P, Nicolson MC, Hannaford PC, Raja EA, Lee AJ, Campbell NC. Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial. Br J Cancer. 2010;102:1447\u201355. https:\/\/doi.org\/10.1038\/sj.bjc.6605638.","journal-title":"Br J Cancer"},{"key":"1841_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archdermatol.2009.350","volume":"146","author":"JK Robinson","year":"2010","unstructured":"Robinson JK, Turrisi R, Mallett K, Stapleton J, Pion M. Comparing the efficacy of an in-person intervention with a skin self-examination workbook. Arch Dermatol. 2010;146:91\u20134. https:\/\/doi.org\/10.1001\/archdermatol.2009.350.","journal-title":"Arch Dermatol"},{"key":"1841_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/jamadermatol.2015.0690","volume":"151","author":"R Turrisi","year":"2015","unstructured":"Turrisi R, Hultgren B, Mallett KA, Martini M, Robinson JK. Comparison of efficacy of differing partner-assisted skin examination interventions for melanoma patients: a randomized clinical trial. JAMA Dermatol. 2015;151:945\u201351. https:\/\/doi.org\/10.1001\/jamadermatol.2015.0690.","journal-title":"JAMA Dermatol"},{"key":"1841_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11764-014-0412-0","volume":"9","author":"DJ Bowen","year":"2015","unstructured":"Bowen DJ, Burke W, Hay JL, Meischke H, Harris JN. Effects of web-based intervention on risk reduction behaviors in melanoma survivors. J Cancer Surviv. 2015;9:279\u201386. https:\/\/doi.org\/10.1007\/s11764-014-0412-0.","journal-title":"J Cancer Surviv"},{"key":"1841_CR16","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1002\/cam4.3299","volume":"9","author":"JK Robinson","year":"2020","unstructured":"Robinson JK, Reavy R, Mallett KA, Turrisi R. Remote skin self-examination training of melanoma survivors and their skin check partners: a randomized trial and comparison with in-person training. Cancer Med. 2020;9:7301. https:\/\/doi.org\/10.1002\/cam4.3299.","journal-title":"Cancer Med"},{"key":"1841_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","volume":"158","author":"DM Ackermann","year":"2022","unstructured":"Ackermann DM, Dieng M, Medcalf E, Jenkins MC, van Kemenade CH, Janda M, et al. Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial. JAMA Dermatol. 2022;158:33\u201342. https:\/\/doi.org\/10.1001\/jamadermatol.2021.4704.","journal-title":"JAMA Dermatol"},{"key":"1841_CR18","doi-asserted-by":"publisher","first-page":"e37539","DOI":"10.2196\/37539","volume":"8","author":"P Murchie","year":"2022","unstructured":"Murchie P, Constable L, Hall S, Brant W, Allan J, Johnston M, et al. The achieving self-directed integrated cancer aftercare intervention for detection of recurrent and second primary melanoma in survivors of melanoma: pilot randomized controlled trial. JMIR Cancer. 2022;8: e37539. https:\/\/doi.org\/10.2196\/37539.","journal-title":"JMIR Cancer"},{"key":"1841_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2023.6158","volume":"160","author":"AN Mahama","year":"2024","unstructured":"Mahama AN, Haller CN, Labrada J, Idiong CI, Haynes AB, Jacobs EA, et al. Lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma. JAMA Dermatol. 2024;160:495\u2013501. https:\/\/doi.org\/10.1001\/jamadermatol.2023.6158.","journal-title":"JAMA Dermatol"},{"key":"1841_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3256","author":"NM Helvind","year":"2023","unstructured":"Helvind NM, Brinch-M\u00f8ller Weitemeyer M, Chakera AH, Hendel HW, Elleb\u00e6k E, Svane IM, et al. Stage-specific risk of recurrence and death from melanoma in denmark, 2008\u20132021: a national observational cohort study of 25 720 patients with stage IA to IV melanoma. JAMA Dermatol. 2023. https:\/\/doi.org\/10.1001\/jamadermatol.2023.3256.","journal-title":"JAMA Dermatol"},{"key":"1841_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ecc.12901","volume":"27","author":"T Wagner","year":"2018","unstructured":"Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, et al. Fear of cancer progression in patients with stage IA malignant melanoma. European Journal of Cancer Care. 2018;27:27. https:\/\/doi.org\/10.1111\/ecc.12901.","journal-title":"Eur J Cancer Care"},{"key":"1841_CR22","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/pon.4366","volume":"26","author":"KJL Bell","year":"2017","unstructured":"Bell KJL, Mehta Y, Turner RM, Morton RL, Dieng M, Saw R, et al. Fear of new or recurrent melanoma after treatment for localised melanoma. Psychooncology. 2017;26:1784\u201391. https:\/\/doi.org\/10.1002\/pon.4366.","journal-title":"Psychooncology"},{"key":"1841_CR23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s11136-020-02464-y","volume":"29","author":"K Lisy","year":"2020","unstructured":"Lisy K, Lai-Kwon J, Ward A, Sandhu S, Kasparian NA, Winstanley J, et al. Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study. Qual Life Res. 2020;29:2021\u20137. https:\/\/doi.org\/10.1007\/s11136-020-02464-y.","journal-title":"Qual Life Res"},{"key":"1841_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4143\/crt.2021.835","volume":"54","author":"TXM Tran","year":"2022","unstructured":"Tran TXM, Jung SY, Lee EG, Cho H, Kim NY, Shim S, et al. Fear of cancer recurrence and its negative impact on health-related quality of life in long-term breast cancer survivors. Cancer Res Treat. 2022;54:1065\u201373. https:\/\/doi.org\/10.4143\/crt.2021.835.","journal-title":"Cancer Res Treat"},{"key":"1841_CR25","doi-asserted-by":"publisher","unstructured":"Williams JTW, Pearce A, Smith A \u201cBen.\u201d A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology. 2021;30:1185\u201395. https:\/\/doi.org\/10.1002\/pon.5673.","DOI":"10.1002\/pon.5673"},{"key":"1841_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/pon.5568","volume":"30","author":"E Vachon","year":"2021","unstructured":"Vachon E, Krueger E, Champion VL, Haggstrom DA, Cella D, Cohee AA. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials. Psychooncology. 2021;30:279\u201386. https:\/\/doi.org\/10.1002\/pon.5568.","journal-title":"Psychooncology"},{"key":"1841_CR27","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1200\/JCO.2016.68.2278","volume":"34","author":"M Dieng","year":"2016","unstructured":"Dieng M, Butow PN, Costa DSJ, Morton RL, Menzies SW, Mireskandari S, et al. Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. J Clin Oncol. 2016;34:4405\u201314. https:\/\/doi.org\/10.1200\/JCO.2016.68.2278.","journal-title":"J Clin Oncol"},{"key":"1841_CR28","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1200\/JCO.2017.73.1257","volume":"35","author":"PN Butow","year":"2017","unstructured":"Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, et al. Randomized trial of conquerfear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. JCO. 2017;35:4066\u201377. https:\/\/doi.org\/10.1200\/JCO.2017.73.1257.","journal-title":"JCO"},{"key":"1841_CR29","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00520-018-4574-6","volume":"27","author":"L Russell","year":"2019","unstructured":"Russell L, Ugalde A, Orellana L, Milne D, Krishnasamy M, Chambers R, et al. A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma. Support Care Cancer. 2019;27:2735\u201346. https:\/\/doi.org\/10.1007\/s00520-018-4574-6.","journal-title":"Support Care Cancer"},{"key":"1841_CR30","doi-asserted-by":"publisher","unstructured":"Murphy Mj, Newby Jm, Butow P, Loughnan Sa, Joubert Ae, Kirsten L, et al. Randomised controlled trial of internet-delivered cognitive behaviour therapy for clinical depression and\/or anxiety in cancer survivors (iCanADAPT Early). Psycho-Oncol. 2020;29:76\u201385. https:\/\/doi.org\/10.1002\/pon.5267.","DOI":"10.1002\/pon.5267"},{"key":"1841_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2340\/1651-226X.2024.41037","volume":"63","author":"SM Hansen","year":"2024","unstructured":"Hansen SM, Johansen C, Obinah MPB, Kasparian NA, Genter P, Bidstrup PE, et al. MELACARE nurse-led follow-up after early-stage melanoma: protocol and feasibility. Acta Oncol. 2024;63:909\u201314. https:\/\/doi.org\/10.2340\/1651-226X.2024.41037.","journal-title":"Acta Oncol"},{"key":"1841_CR32","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ (Online). 2010;340:698\u2013702. https:\/\/doi.org\/10.1136\/bmj.c332.","journal-title":"BMJ (Online)"},{"key":"1841_CR33","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687. https:\/\/doi.org\/10.1136\/bmj.g1687.","journal-title":"BMJ"},{"key":"1841_CR34","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1007\/s00520-016-3339-3","volume":"24","author":"NA Kasparian","year":"2016","unstructured":"Kasparian NA, Mireskandari S, Butow PN, Dieng M, Cust AE, Meiser B, et al. \u201cMelanoma: Questions and Answers\u201d. Development and evaluation of a psycho-educational resource for people with a history of melanoma. Support Care Cancer. 2016;24:4849\u201359. https:\/\/doi.org\/10.1007\/s00520-016-3339-3.","journal-title":"Support Care Cancer."},{"key":"1841_CR35","first-page":"139","volume":"3","author":"JN Cornier","year":"2005","unstructured":"Cornier JN, Davidson L, Xing Y, Webster K, Cella D. Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol. 2005;3:139\u201345.","journal-title":"J Support Oncol"},{"key":"1841_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/cncr.23424","volume":"112","author":"J Cornier","year":"2008","unstructured":"Cornier J, Ross M, Gershenwald J, Lee J, Mansfield P, Camacho L, et al. Prospective assessment of the reliability, validity, and sensitivity to change of the Functional assessment of cancer therapy-melanoma questionnaire. Cancer. 2008;112:2249\u201357.","journal-title":"Cancer"},{"key":"1841_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11764-014-0383-1","volume":"9","author":"B Thewes","year":"2015","unstructured":"Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68\u201379. https:\/\/doi.org\/10.1007\/s11764-014-0383-1.","journal-title":"J Cancer Surviv"},{"key":"1841_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"key":"1841_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Decker O, M\u00fcller S, Br\u00e4hler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46:266\u201374. https:\/\/doi.org\/10.1097\/MLR.0b013e318160d093.","journal-title":"Med Care"},{"key":"1841_CR40","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA. 1999;282:1737\u201344. https:\/\/doi.org\/10.1001\/jama.282.18.1737.","journal-title":"JAMA"},{"key":"1841_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"key":"1841_CR42","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/(sici)1097-0142(19980515)82:10<1904::aid-cncr13>3.0.co;2-x","volume":"82","author":"AJ Roth","year":"1998","unstructured":"Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1904\u20138. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19980515)82:10%3c1904::aid-cncr13%3e3.0.co;2-x.","journal-title":"Cancer"},{"key":"1841_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pon.3430","volume":"23","author":"KA Donovan","year":"2014","unstructured":"Donovan KA, Grassi L, McGinty HL, Jacobsen PB. Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014;23:241\u201350. https:\/\/doi.org\/10.1002\/pon.3430.","journal-title":"Psychooncology"},{"key":"1841_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372. https:\/\/doi.org\/10.1016\/0168-8510(96)00822-6.","journal-title":"Health Policy"},{"key":"1841_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/occmed\/kqm008","volume":"57","author":"J Ilmarinen","year":"2007","unstructured":"Ilmarinen J. The Work Ability Index (WAI). Occup Med. 2007;57:160. https:\/\/doi.org\/10.1093\/occmed\/kqm008.","journal-title":"Occup Med"},{"key":"1841_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5271\/sjweh.1304","volume":"35","author":"J Ilmarinen","year":"2009","unstructured":"Ilmarinen J. Work ability\u2013a comprehensive concept for occupational health research and prevention. Scand J Work Environ Health. 2009;35:1\u20135. https:\/\/doi.org\/10.5271\/sjweh.1304.","journal-title":"Scand J Work Environ Health"},{"key":"1841_CR47","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","volume":"39","author":"JH Hibbard","year":"2004","unstructured":"Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39:1005\u201326. https:\/\/doi.org\/10.1111\/j.1475-6773.2004.00269.x.","journal-title":"Health Serv Res"},{"key":"1841_CR48","doi-asserted-by":"publisher","unstructured":"Van Der Laan MJ, Rose S. Targeted learning: causal inference for observational and experimental data. https:\/\/doi.org\/10.1007\/978-1-4419-9782-1.","DOI":"10.1007\/978-1-4419-9782-1"},{"key":"1841_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v051.i13","volume":"51","author":"S Gruber","year":"2012","unstructured":"Gruber S, van der Laan M. tmle: an R package for targeted maximum likelihood estimation. J Stat Softw. 2012;51:1\u201335. https:\/\/doi.org\/10.18637\/jss.v051.i13.","journal-title":"J Stat Softw"},{"key":"1841_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/s0190-9622(99)70437-8","volume":"40","author":"H Kittler","year":"1999","unstructured":"Kittler H, Seltenheim M, Dawid M, Pehamberger H, Wolff K, Binder M. Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy. J Am Acad Dermatol. 1999;40:558\u201362. https:\/\/doi.org\/10.1016\/s0190-9622(99)70437-8.","journal-title":"J Am Acad Dermatol"},{"key":"1841_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejon.2017.10.002","volume":"31","author":"G Kotronoulas","year":"2017","unstructured":"Kotronoulas G, Connaghan J, Grenfell J, Gupta G, Smith L, Simpson M, et al. Employing patient-reported outcome (PRO) measures to support newly diagnosed patients with melanoma: feasibility and acceptability of a holistic needs assessment intervention. Eur J Oncol Nurs. 2017;31:59\u201368. https:\/\/doi.org\/10.1016\/j.ejon.2017.10.002.","journal-title":"Eur J Oncol Nurs"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-025-01841-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:08:46Z","timestamp":1792231726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-025-01841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":51,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1007\/s11764-025-01841-1","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted following the principles of the Declaration of Helsinki. A waiver was obtained from the regional scientific committee (H-21045132), and the study was registered at ClinicalTrials.gov (identifier: NCT05253872) before recruitment.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participating patients before study inclusion.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or non-financial conflicts of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}